Princeton, NJ -- (SBWIRE) -- 06/06/2018 -- The Global Companion Diagnostics Market was estimated to be US$1.6 billion in 2015, and nearly US$1.9 billion at the end of 2016. Driven by the growth in targeted therapies coming to market and wider use of CDx is multiple therapy areas, the market is expected to accelerate to reach US$6.09 billion by the end of 2021, growing at a CAGR of 25.1% for the period 2016 through 2021.

Browse details of 352 pages in-depth research report developed on Global Companion Diagnostics Market @ https://www.researchcosmos.com/reports/global-companion-diagnostics-market-analysis-with-forecasts-to-2022-growth-opportunities/143605992

Key to making personalized medicine a reality, companion diagnostics are playing a critical role in the accurate diagnosis of disease and enabling the efficient use of targeted therapies. This highly-complex sector continues to innovate, as exemplified by the development of liquid biopsy technology which introduces a new, non-invasive and cost-effective way for clinicians to make treatment adjustments.

"As genomic research identifies new disease states and patient sub populations, the pharma industry and clinicians must be able to respond with specific targeted medicines. Companion diagnostics are changing the way powerful new targeted medicines are utilized to the benefit of patients, physicians and health payers," said Research Cosmos

The report "Global Companion Diagnostics Market Analysis with Forecasts to 2022 | Growth Opportunities" is a comprehensive and highly detailed 363-page market research report which presents expert analysis of the current market, forecasted future value, market environment, technical innovations and companies which are shaping the critical companion diagnostic sector.

Avail Sample Market Brochure of the report for more information to evaluate report usefulness, Get a Copy @ https://www.researchcosmos.com/request/143605992

Report Scope:

The scope of the report encompasses the major types of diagnostics technologies that have been used, the various industry structures such as the lab developed tests (LDTs) sector, and the major applications being commercialized and developed by a wide range of company types. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed.

Report Includes:

- An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
- Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
- Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
- Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.

Got some questions, Inquire @ https://www.researchcosmos.com/inquire/143605992

About Research Cosmos:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We're associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

Contact Us:
Kevin Stewart
Sales Manager
Research Cosmos
www.researchcosmos.com
kevin@researchcosmos.com
# +1 888 709 8757